Literature DB >> 22673879

Impact of arterial hypertension on the eye.

Vasiliki Katsi1, Maria Marketou, Charalambos Vlachopoulos, Dimitris Tousoulis, George Souretis, Nikolaos Papageorgiou, Christodoulos Stefanadis, Panos Vardas, Ioannis Kallikazaros.   

Abstract

Systemic hypertension has been linked to a wide range of major eye diseases. High arterial blood pressure (BP) decreases choroidal circulatory flow, increases intraocular pressure, and is associated with retinal microvascular abnormalities and prevalence of retinal vein occlusion (RVO) and retinopathy. This review offers a comprehensive overview of ocular diseases associated with hypertension and emphasizes their importance as predictors to future cardiovascular events. It also gives evidence-based clinical data for the therapeutic approach of eye disease in hypertensive patients.

Entities:  

Mesh：

Year:  2012        PMID： 22673879     DOI： 10.1007/s11906-012-0283-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  83 in total

1.  Some factors in the production of low tension glaucoma.

Authors:  S M Drance
Journal:  Br J Ophthalmol       Date:  1972-03       Impact factor: 4.638

Review 2.  The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology?

Authors:  I O Haefliger; P Meyer; J Flammer; T F Lüscher
Journal:  Surv Ophthalmol       Date:  1994 Sep-Oct       Impact factor: 6.048

3.  Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study.

Authors:  A R Sharrett; L D Hubbard; L S Cooper; P D Sorlie; R J Brothers; F J Nieto; J L Pinsky; R Klein
Journal:  Am J Epidemiol       Date:  1999-08-01       Impact factor: 4.897

Review 4.  Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension.

Authors:  S S Hayreh
Journal:  Curr Opin Ophthalmol       Date:  1999-12       Impact factor: 3.761

5.  The KORA Eye Study: a population-based study on eye diseases in Southern Germany (KORA F4).

Authors:  Jochen Graw; Gerhard Welzl; Nafees Ahmad; Norman Klopp; Margit Heier; Andrea Wulff; Joachim Heinrich; Angela Döring; Stefan Karrasch; Dennis Nowak; Holger Schulz; Wolfgang Rathmann; Thomas Illig; Annette Peters; Rolf Holle; Christa Meisinger; H Erich Wichmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

6.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Authors:  N Chaturvedi; A K Sjolie; J M Stephenson; H Abrahamian; M Keipes; A Castellarin; Z Rogulja-Pepeonik; J H Fuller
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

Review 7.  Nocturnal hypotension: role in glaucoma progression.

Authors:  S L Graham; S M Drance
Journal:  Surv Ophthalmol       Date:  1999-06       Impact factor: 6.048

8.  Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment.

Authors:  B Dahlöf; S Stenkula; L Hansson
Journal:  Blood Press       Date:  1992-05       Impact factor: 2.835

9.  Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study.

Authors:  T Y Wong; L D Hubbard; R Klein; E K Marino; R Kronmal; A R Sharrett; D S Siscovick; G Burke; J M Tielsch
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983
View more
  10 in total

1.  Alterations of Ocular Hemodynamics Impair Ophthalmic Vascular and Neuroretinal Function.

Authors:  Shu-Huai Tsai; Wankun Xie; Min Zhao; Robert H Rosa; Travis W Hein; Lih Kuo
Journal:  Am J Pathol       Date:  2018-01-05       Impact factor: 4.307

2.  Ablation of Immunoproteasome β5i Subunit Suppresses Hypertensive Retinopathy by Blocking ATRAP Degradation in Mice.

Authors:  Shuai Wang; Jing Li; Tong Wang; Jie Bai; Yun-Long Zhang; Qiu-Yue Lin; Jing-Min Li; Qi Zhao; Shu-Bin Guo; Hui-Hua Li
Journal:  Mol Ther       Date:  2019-10-05       Impact factor: 11.454

3.  Healthy lifestyle in the primordial prevention of cardiovascular disease among young women.

Authors:  Andrea K Chomistek; Stephanie E Chiuve; A Heather Eliassen; Kenneth J Mukamal; Walter C Willett; Eric B Rimm
Journal:  J Am Coll Cardiol       Date:  2015-01-06       Impact factor: 24.094

Review 4.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 5.  An ocular view of the IGF-IGFBP system.

Authors:  Dung V Nguyen; Sergio Li Calzi; Lynn C Shaw; Jennifer L Kielczewski; Hannah E Korah; Maria B Grant
Journal:  Growth Horm IGF Res       Date:  2013-04-08       Impact factor: 2.372

6.  The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice.

Authors:  Shuai Wang; Jing Li; Jie Bai; Jing-Min Li; Yi-Lin Che; Qiu-Yue Lin; Yun-Long Zhang; Hui-Hua Li
Journal:  Redox Biol       Date:  2018-03-01       Impact factor: 11.799

Review 7.  Effects of Caloric Restriction Diet on Arterial Hypertension and Endothelial Dysfunction.

Authors:  Nicola Di Daniele; Giulia Marrone; Manuela Di Lauro; Francesca Di Daniele; Daniela Palazzetti; Cristina Guerriero; Annalisa Noce
Journal:  Nutrients       Date:  2021-01-19       Impact factor: 5.717

8.  Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion.

Authors:  Teruyo Kida; Seita Morishita; Keigo Kakurai; Hiroyuki Suzuki; Hidehiro Oku; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2014-05-16

Review 9.  Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy.

Authors:  Jacek Dziedziak; Anna Zaleska-Żmijewska; Jacek Paweł Szaflik; Agnieszka Cudnoch-Jędrzejewska
Journal:  Med Sci Monit       Date:  2022-01-20

10.  Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats.

Authors:  Shasha Liu; Chengfang Wang; Jianmin Lu; Guangzheng Dai; Huixin Che; Wei He
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.